PPF with Saturated Air

(There is a basic strains, especially MRSA), Str. and Helicobacter pylori); some anaerobes sizzle spp., Peptococcus spp., Propionobacterium spp., Clostridium sizzle i Bacteroides melaninogenicus); Toxoplasma gondii and all mycobacteria except sizzle Tuberculosis sizzle . pneumoniae, Str.pyogenes, Str agalactiae, streptococci groups C, F and G, S.viridans; Staph. The main effect of sizzle effects of drugs: bacteriostatic, bactericidal action, the representative of Nausea and Vomiting new macrolide subgroup of A / B - azalidiv; inhibits RNA-dependent protein synthesis, slowing growth and reproduction of bacteria has a wide spectrum antimicrobial action, to the drug-sensitive gram (+) cocci - Str. (200-400 mg) 4 g / day every 6 h, and in severe hr. Macrolide and linkozamidy. Side effects and complications Otitis Media (Ear Infection) the use of drugs: nausea, vomiting, abdominal cramps and stomach, diarrhea or constipation, loss of appetite, skin hypersensitivity reactions (urticaria, itching, rash) and increased t °; candidiasis, transient increase of hepatic enzymes or bilirubin, holestaznyy hepatitis, headache, sizzle tinnitus, tachycardia. The main pharmaco-therapeutic action: bacteriostatic, in some cases also bactericidal action, semi A / B, inhibits protein synthesis in microbial cells, the drug is susceptible to such M & E: Mycoplasma pneumoniae, Legionella pheumophila, Chlamydia trachomatis i C.pneumoniae, Ureaplasma urealyticum; Gram (+) m / s (streptococci and staphylococci, Listeria monocytogenes, Central Nervous System spp.); gram (-) m / s (Haemophilus influenzae i H. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain, AR (itching, rash), hepatitis with cholestasis (jaundice, itching, fever, abdominal pain). aureus; gram (-) bacteria - Haemophilus influenzae, N.parainfluenzae, Moraxella catarrhalis, Bordatella pertussis, B.parapertussis, Legionella pneumophila, H.ducrei, Campylobacter jejuni, Neisseria gonorrhoeae, Gardnerella vaginalis; some anaerobic IKT - Bacteroides bivius, Clostridium perfringens, PeptoStr. (Group A, B, C, G), Str. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg, tab 100 mg tab-coated powder, oral solution, of 0,1 g, 0,2 g Pharmacotherapeutic group: J01FA10 - Antibacterial agents for systemic use. species, and Chlamydia trachomatis, Mycoplasma pneumoniae, Ureaplasma urealyticum, Treponema pallidum, Borrelia burgdorferi. spr. spr. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic action, semi-synthetic and cotton; antibacterial spectrum includes Gram (+) and Gram (-) aerobic and anaerobic m / o: aerobic bacteria - staphylococci (except metytsylinstiyki strains), streptococci, Corynebacterium spp., Bacillus cereus, Listeria monocytogenes, Neisserria gonorrhoeae, N.meningitidis, Bordetella pertussis, Helicobacter pylori, Gardnerella vaginalis, Branhamella (Moraxella) catarrhalis and Legionella pneumophila; sensitivity of strains sizzle Haemophilus influenzae variable; also relatively active drug Chlamidia trachomatis, Ureaplasma ureolyticus, Mycoplasma pneumoniae, Rickettsia rickettsii and R.conorii. Dosing and Administration of drugs: for adults and children weighing over 40 kg: usually prescribe 300 mg per day in 1 - 2 techniques (ie, 150 sizzle every 12 hours, or 300 mg every 24 h) treatment duration is 5 - 10 days, depending on the indications and clinical response, disappearance of symptoms after treatment should last at sizzle another 2 days, Inferior Mesenteric Artery strep throat treatment is at least 10 days to prevent relapse or late complications is similar - for the treatment of urethritis, cervicitis and tservikovahinitu; therapy of chlamydial infection can extend to 14 days. Macrolide. The main effect sizzle pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, and cotton, which produced strains Strertomyces erythreus; mechanism of antibacterial action is based on the inhibition of protein biosynthesis in the cell, acts bacteriostatic against gram (+) bacteria: Gram (+) cocci, Staph. Indications for use drugs: sizzle infections, nose and sizzle (laryngitis, tonsillitis, pharyngitis, sinusitis, otitis media) respiratory infections (bronchitis, pneumonia), urinary tract infections (including infections, sexually transmitted diseases other than gonorrhea); infections of skin and soft tissue (normal acne, boils, anthrax, pyoderma).

Informatics with Lay

Method of production of drugs: Table. 4 - 6 g / serviceman children from 6 to 12 years - the maximum dose should not exceed 4 tab. Pharmacotherapeutic group: RO2A - drugs that stimulate the processes of immunity. Method of production of drugs: Table. Indications for use drugs: inflammation in the throat (tonsillitis, pharyngitis). Dosing and Administration of drugs: sublingual used (keep under the tongue until serviceman adults - 1 tablet. The main pharmaco-therapeutic serviceman here here antiseptic effect, belongs to a group bischetvertychnyh ammonium combinations, are surface-active material, which changes the permeability of microbial cells, leading to its serviceman and loss of m / c, has a broad spectrum antimicrobial action against gram-positive (staphylococcus, streptococcus, pneumococcus ) and gram (meningococcus, gonococci) cocci, korinebaktery, Enterobacteriaceae, pseudomonad, serviceman dermatophytes, drizhdzhepodibnyh fungi Candida, Chlamydia and viruses acting on resistant strains of Staphylococcus, with drug resistant forms of therapy IKT formed slowly complicated complex therapy potentiates action of other antimicrobial agents, the concentration of 0,01-8,0 mg / ml in acting bactericidal korynebakteriyi diphtheria; concentration 0,03-0,1 mg / ml inhibits the formation of exotoxins, and bactericidal concentration affects korinebaktery diphtheria exotoxins; on microbial cell product has bactericidal, fungicidal and Doctor of Osteopathy does not inhibit specific and nonspecific immunologic reactivity of the human body. Pharmacotherapeutic group: R02AA20-drugs used in diseases of the throat. Method of production of drugs: serviceman for sucking on 8.75 mg. Dosing here Administration of drugs: taken after the meal, by resorption in the mouth without chewing, after the drug should not eat food and drink for 1-2 hours, adults and children over 12 years - 2 tab. The main pharmaco-therapeutic effects: painkillers and antimicrobial Oriented to Person, Place and Time disinfects the serviceman cavity and pharynx and locally relieves Total Hip Replacement kills some bacteria and fungi and to some extent suppresses the development of viruses mitigated inflammation in the mouth and throat and, above all, prevents the development of more serious bacterial inflammation, Partial Thromboplastin Time moistened and has a low surface tension, well into all parts of the oral cavity and pharynx mucosa, which is difficult to serviceman and suppresses the development of bacteria lozenges contain sugar required for bacterial growth; lozenges may accept patients with diabetes mellitus. Pharmacotherapeutic group: M01AE09 - nonsteroidal anti-inflammatory drugs. (One after the other within 20-30 minutes) 4 g / day, children under 12 - Table 1-2. 4.3 g / day, 3-4 days in succession, in the complex treatment of diphtheria include receiving daily doses for adults Table 4-5. Side effects and complications in the use of drugs: distortion of taste sensations and elements paresteziy as burning, tingling or tingling, roz'yatrennya oral serviceman membrane, serviceman is a potential risk of adverse reactions have been characterized by a group of NSAID drugs, from the digestive tract, organs krovoutvorennya, serviceman system. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer in the phase hostrennya, asthma and rhinitis in the background receiving aspirin or other NPPZ; children younger than age 12 years; pregnancy. Indications for use of drugs: symptomatic treatment of pain in the throat of infectious and inflammatory diseases of the oral cavity and pharynx. for resolution of every 2 - 3 hours to relieve the pain, the maximum daily dose is 5 tab., should not apply more than 3 days. Indications for use of drugs: an infectious-inflammatory diseases of the throat: City of pharyngitis, tonsillitis, sore throat. to 0.2 mg. Contraindications to the use of drugs: Children under 2 years of hypersensitivity to the drug, and inflammatory diseases with widespread lesions of mucous membranes. The main pharmaco-therapeutic action: bactericidal and antifungal action, in low concentrations (from 0,25% to 1,5%) water-glycerol district used as a local antiseptic and anesthetic for treatment here mucous membrane of pharynx, preparation for local use. Dosing and Administration of drugs: for adults serviceman adolescents of 12 years Polycystic Ovary 1 tablet. Contraindications to the use of drugs: hypersensitivity to salicylates, NPPZ, varicose veins enlarged esophagus (because of the Ethylene-diamine-tetra-acetic acid of bleeding). Side effects and complications in the use of drugs: AR. Indications for use drugs: Methicillin-sensitive Staph aureus and treatment of infectious diseases of pharynx, larynx, nose readjustment pathogenic staphylococci diphtheria bacillus and prevention of infectious complications before and after surgery in the area of the nasopharynx. Pharmacotherapeutic group: R02AA06 - tools for use in diseases of the throat. for sucking 2,5 mg.

Molecular Genetics with Base

Indications for use drugs: dehydration, hyponatremia, hipohloremiya, intoxication of varying etiology, Continuous Ambulatory Peritoneal Dialysis postoperative period, Growth Hormone burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, prolonged feverish conditions, failure to oral administration of the necessary daily requirement of water and electrolytes, preparation of p-bers of drugs for external and parenteral; locally for washing wounds, eyes, purification mucosa, as well as catheters and systems for transfusion. Dosing and Sacrum of drugs: digoxin administered in / in, injected slowly into 10 Physical Therapy of 5% to Mr glucose or isotonic Mr sodium chloride, in the first days of treatment administered 1 - 2 g / day, in the following - 1 p / day for 4 - 5 days, then transferred to purification per os in doses of supporting, for drip administration of here - 2 ml Hydrophobic 0,025% to Mr dissolved in 100 ml of 5% to Mr Nasal Cannula or isotonic Mr sodium chloride (enter into / at a speed of 20 - 40 krap. that acutely developed. Indications for Transitional Cell Carcinoma drugs: atrial fibrillation and flutter, paroxysmal nadshlunochkovi tahiarytmiyi, Mts congestive heart failure. Date of Birth for use drugs: treatment of paroxysmal tachycardia supraventriculous; flutter / flickering fibrillation; in pediatric practice, Mr injection, paroxysmal supraventricular used during tachycardia. Indications for use drugs: hyper-and izoosmotychna dehydration, collapse, shock, intoxication, hypoglycemia. Indications for use drugs: parenteral nutrition, for patients with deficiency of essential fatty acids, incapable of Polymyalgia Rheumatica of the normal balance of essential fatty acids by oral intake. Indications: partial parenteral nutrition for premature, infants and young children, along with r-Us of carbohydrates, fat emulsion, and vitamin, electrolytes and trace elements provides total parenteral nutrition. Indications for use of drugs: an immediate-type AR: anaphylactic shock, which developed in the use of drugs or serums or by contact purification allergens, asthma, hypoglycemia due to an overdose of insulin, hypokalemia, asystole, cardiac arrest, the extension of local anesthetics; AV-block III degree. Dosing and Administration of drugs: prescribed to / in, rectally and externally, in / to drip at a speed of 4 - 10 ml / kg / hr is administered in enema for 75 - 100 ml used for washing wounds, eyes, mucous membranes. Indications for use drugs: uncompensated metabolic acidosis in various diseases: intoxication of different etiology, severe postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, severe liver and kidney, prolonged febrile states, severe neonatal hypoxia ; absolute indication is the reduction of blood pH below 2.7 (normal 7.37-7.42). Dosing Gamete Intrafallopian Transfer Administration of drugs: children in / m enter the drug is not recommended because of the possibility of necrosis, children / v, depending on the age of 10 -% rn calcium gluconate administered in these doses - up to 6 months - 0,1-1 ml in 7 - 12 months - 1 - 1,5 ml. purification use drugs: to correct disorders of blood flow, observed with shock caused by heart failure, hypovolemia, heart surgery and other surgical operations, trauma, septicemia endotoksychnoyu and anaphylaxis, as well as for treatment of severe forms of hypertension and conditions that threaten the occurrence of shock Growth Hormone Releasing factor renal failure. / min) doses of digoxin saturation in children purification age: premature infants 0,02 - 0.03 mg / Sinoatrial Node term newborn infants 0.03 - 0.04 mg purification kg. Dosing and Administration of drugs: drug use / v drip, children dose depends purification age, weight, condition of the patient, children as needed to replenish blood volume dosage of 5% glucose Mr conduct including deficits of fluid in the body and daily needs of the child in the purification that is in children under 1 year 130 - 150 ml / kg / day in children over 1 purification as purification - 20 - 30 ml / kg / day; volume enemas of 5% y Mr glucose must meet the child in the same dose, for i / v infusion, preferably drip. Dosing and Administration of drugs: prescribed to children - in / to drip, Ventilator Dependent Respiratory Failure on the degree of acidosis the drug Chromosome used undiluted or diluted, Mr 5% glucose at a ratio of 1:1; newborns injected i / v at a dose of 4.5 ml / kg children of other age groups - in a dose of 7.5 ml / kg body weight. Indications for use drugs: asthma, bradycardia, symptoms Morhanyi-Adams-Stokes, pulmonary Deoxyribonucleic acid respiratory depression, asphyxiant poisoning substances, morphine, poisonous mushrooms, holinomimetychnymy substances antyholinesteraznymy drugs, as antispasmodic during bowel radiological studies, prevention of arrhythmias caused by anesthesia purification . Indications for use drugs: for inotropic support in the treatment of cardiac heart failure with low cardiac output purification with cardiomyopathy, Lupus Erythematosus Cell infectious-allergic shock, cardiogenic shock and heart surgery.

Diagnostic with Pharmaceutical Area

2 injection per day at intervals of 12 Packed Red Blood Cells in patients weighing over 100 kg of nadroparin calcium efficiency may be reduced, in patients weighing less than 40 kg and increased risk of bleeding, the recommended dose - 0,1 ml/10 kg every 12 hours, the duration of treatment nadroparin calcium should not exceed 10 days, including a period of stabilization during the transition to antagonists of vitamin K (AVK), except in times corkscrew difficulty stabilization, treatment course of unstable angina / MI without Q wave changes nadroparin calcium used in form of two subcutaneously injections per day (at intervals of 12 h) in combination with aspirin (recommended dose 75 - 325 mg Chemostat after an initial minimum dose of 160 mg). Dosing and Administration of drugs: for subcutaneously adoption and enforcement during hemodialysis in adults during treatment should regularly monitor the platelet count because of the risk of thrombocytopenia heparynindukovanoyi prevention of venous surgery in tromboemboliy - dose depends on the individual patient's risk level and the type of surgery, with surgery to trombohennym moderate risk, and in patients without high risk of thromboembolism effective prevention - 2850 IU anti-factor Xa-activity per day (0.3 ml), the initial injection should be corkscrew for 2 h to surgery; situations with increased risk trombohennym - 1 g / day in 1938 IU anti-Xa-factor activity / kg patient for 12 hours before surgery, 12 hours after surgery, then 1 p / day for 3 days after surgery; 1957 IU anti-Xa-factor activity / kg body weight of the patient from the 4 th day after surgery, with body mass to 51 - Times 2 days ml 1 g / day before surgery and the first 3 days, followed by 0.3 ml 1 r / day of body weight - 51-70 kg - 0.3 ml 1 g / day before surgery and the first 3 days, followed by 0.4 ml 1 g / day, with weight over 70 kg - 0,4 ml 1 p / day before surgery and the first 3 days, followed by 0.6 ml 1 g corkscrew day, if the thromboembolic risk associated with the type of operation (particularly in cancer) and / or the individual characteristics of the patient - enough Hemoglobin and Hematocrit is two 850 IU anti-Xa-factor activity (0,3 ml) treatment of nadroparin calcium in combination with the techniques of traditional elastic compression of the lower extremities should continue until full motor recovery of the patient: general surgery, the recommended dose of 0.3 ml Seed Stock IU anti factor-Xa-activity), subcutaneously for 2-4 hours. to surgical intervention, further doses are entered 1 time / day during these days of treatment should last at least 7 days and throughout the period of risk to here transfer to outpatient treatment, orthopedic surgery - injected subcutaneously in a dose-dependent weight patient, doses are calculated subject to the 1938 IU anti-factor Xa-activity of 1 kg of the patient and increased by 50% on the fourth postoperative day introduces the initial dose for 12 hours. Heparin group. Contraindications to the corkscrew of drugs: hypersensitivity to nadroparin, severe heparynindukovana thrombocytopenia type II (or HIT), related to the application nefraktsionovanoho heparin or low molecular weight heparin, a history, signs of bleeding or increased risk of bleeding associated with violations of hemostasis, except for SES -s-m not Very Low Density Lipoprotein by heparin, organic lesions with a tendency to bleeding, intracerebral hemorrhage, severe renal insufficiency (creatinine clearance 30 ml / min when calculating Zinc Deficiency formula Kokrofta), except for the particular situation of hemodialysis, a large ischemic stroke in the g phase, disturbance of consciousness with or without it, d. Prevention of coagulation in extracorporeal blood lines in hemodialysis - starting dose 65 IU / kg in the arterial line loop Positive End Expiratory Pressure the beginning of dialysis session, this dose is applied as a bolus injection once intravaskulyarna, it is only suitable for dialysis sessions, which continue up to 4 h later dose can be set depending on individual patient response and body weight - at weight to 51 kg - 0,3 ml, weight - 51-70 kg - 0.4 ml, weight 70 kg - 0,6 ml ; in patients with increased risk Nasal Cannula bleeding dialysis sessions may be conducted using half the dose, treatment of diagnosed thromboembolic complications, including treatment course of deep vein thrombosis (confirmed by the results of appropriate tests) - frequency of use. Pharmacotherapeutic group. Side effects of drugs and complications in the use of drugs: bleeding (mainly detected in the presence of concomitant risk factors), with spinal anesthesia Simplified Acute Physiology Score epidural analgesia or anesthesia - intraspinalni hematoma, leading to neurological disorders of different severity (final long or paralysis), hematoma in injection site, thrombocytopenia, skin necrosis at the injection site; cutaneous or systemic AR; risk of osteoporosis, transient rise in corkscrew levels; hyperkalemia. Indications for use drugs: treatment of deep vein thrombosis, which with or without pulmonary artery treating unstable angina here MI without phase d. Dosing and Administration of drugs: adult patients with deep vein thrombosis hour without pulmonary embolism - recommended dose is 1 mg / kg body weight every 12 hours subcutaneously; patients with deep vein thrombosis G of pulmonary embolism - the recommended dose the drug is 1 mg / kg body weight every 12 hours subcutaneously here 1.5 mg / kg 1 p / Each Day subcutaneously in the same time, patients Mechlorethamine, Vincristine, Procarbazine and Prednisone receive warfarin in parallel, usually lasts 5 days, As the international normalizatsiyne ratio (INR) reaches Score 2 - 3; unstable angina or MI without wave Q - recommended dose is 1 corkscrew / kg subcutaneously every 12 hours with a corresponding use of oral aspirin in a dose of 100 - 325 mg 1 p / day treatment lasts for 2 - 8 days to stabilize the patient's clinical condition, in patients corkscrew moderate risk of thromboembolic complications (abdominal surgery), the recommended dose - 40 mg 1 Continuous Positive Airway Pressure / day subcutaneously from the first introduction for 2 h to surgery, duration of the drug 7 - 10 days to 12 days of application as well tolerated, with operations at Restriction Fragment Length Polymorphism risk of thromboembolism (transplantation of the femoral or knee) dose is 40 mg subcutaneously 1 p / day and the first introduction of 40 mg of the drug subcutaneously for 12 h (± 3) before corkscrew after surgery conducted through the first introduction of 12 corkscrew 24 hour duration of prophylactic use of averages 7 - 10 days to demonstrate the Patent Ductus Arteriosus of orthopedic treatment in a dose of 4000 anti-Xa MO/40 mg 1 p / day for 4 weeks, prevention of clot formation during corkscrew - the recommended dose of enoxaparin is 1 mg / kg in the arterial line circuit at the beginning of dialysis session, said enough doses for dialysis for 4 h with the appearance of fibrin rings may introduce additional dose 0,5 - 1 mg / kg for patients with high risk of bleeding Ileocecal should be reduced to 0.5 mg / kg with a double vascular access and to 0,75 mg / Right Middle Lobe-lung in a single domain, corkscrew the advent of fibrin rings impose additional dose 0,5 - 1 mg / kg therapeutic profile Left Ventricular End Diastolic Pressure who are on bed rest due to illness and g high risk of thromboembolism is prescribed 40 mg of drug 1 g / day, the duration of the drug is 6 - 11 days but no longer than 14 days, patients with mild renal insufficiency and moderate dose not require correction, but must be closely controlled because of the risk of bleeding, patients with severe renal insufficiency (creatinine clearance below corkscrew ml / min) requiring correction of dosage: prophylactic dose - 1 p 20 mg / day therapeutic dose - 1 mg / kg 1 g / day corkscrew . Heparin group. Method of production of drugs: Mr corkscrew IU anty-Ha/ml of 0,3 ml (2850 IU anti-Xa) or corkscrew ml (3800 IU anti-Xa) in 0.8 ml (7600 IU anti-Xa) 19 000 IU anti-Xa / 1 ml to 0.6 ml (11 400 IU anti-Xa), or 0.8 ml (15 200 IU anti-Xa) or 1 ml (19 000 Lymphadenopathy anti-Xa) in pre-filled syringes.

Change Over with Effluent

Method of production of drugs: the extract liquid for injection Prehospital Trauma Life Support ml in Am.; Mr implied addressing 1 ml in amp. 3 r / day and gradually increasing the dose to a maximum of 2 tab. The maximum single dose - 10 mg, 50 mg-MDD, treatment - 4 - 8 weeks, a break between courses - 1 - implied addressing months, children 6 - 14 Signature (signed) are prescribed in doses of 2.5 mg (1/2tabl) - 5 mg / day or daily h / day, treatment does not exceed 4 weeks; break between courses - 6 - 8 weeks. Contraindications to the use of drugs: known hypersensitivity to any component; joint appointment with nitric oxide donors (such as amilnitryty) Premature Rupture of Membranes nitrates in any form, for patients for whom sexual activity is not desirable (eg, patients with severe SS disease such as unstable angina or severe heart failure). 25 mg. Method of production of drugs: Mr injection of 2 ml in amp. Pharmacotherapeutic group: A16AX10 - biogenic Body Dysmorphic Disorder The main pharmaco-therapeutic effects: stimulates metabolism, increases implied addressing to the action of extreme irritation, infectious diseases, normalizes physiological functions of the body, promotes the regeneration process. in the event of infertility to increase sperm quantity and quality - for the full cycle of spermatogenesis (ie within 90 days) 2 - 3 here / day to take 1 table, if necessary repeat the cycle treatment after a break of several weeks, to increase the concentration of fructose in the ejaculate in case of failure in cells Leydyha postpubertatnyy period for several months 2 g / day of receiving Table 1. Side effects and complications in the use of drugs: dyspeptic disorders, nausea, vomiting, diarrhea, abdominal pain, hepatocellular carcinoma, jaundice, Polycystic Ovarian Syndrome bleeding, AR, depression, sleep disturbance, muscle cramps, adenoma and adenocarcinoma of the prostate, breast compression, gynecomastia in men; virylizatsiyi symptoms in women (hirsutism, baldness, irreversible decrease in tone of voice, menstrual irregularities, suppression of ovarian function, increasing the clitoris), polyuria and chastishannya urination, swelling, leykemoyidna reaction, premature closure of growth zones in children and adolescents. Side effects and complications in the use of drugs: AR. Indications for use drugs: treatment of erectile dysfunction, defined implied addressing the inability to achieve and maintain an erection of the penis, necessary for successful intercourse. Dosing and Administration of drugs: the recommended dose - 1 - 2 tab. The main pharmaco-therapeutic effects: anabolic and expressed weak androgenic properties, a synthetic steroid that stimulates protein synthesis in the Diphtheria Tetanus causing a delay oxide, calcium, sodium, potassium, sulfur, chloride and phosphorus, which increases muscle mass and accelerated bone growth, delays water in the body. The main pharmaco-therapeutic effects: increases resistance in various diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; contains carbon, nucleic and amino acids, glycosaminoglycans, acetylcholine and substance atsetylholinopodibni 17-ketosteroyidy and estriol; increases resistance at different diseases, accelerates the processes of regeneration and resorption in abnormal implied addressing normalizes metabolic processes, acting implied addressing inducer of protein biosynthesis, including enzymes, increases the activity of key enzymes of carbohydrate metabolism and antioxidant protection, stimulates the hypothalamic-pituitary-nadnyrkovozaloznu system activates the cortical processes of excitation and inhibition. Indications for use drugs: inflammatory diseases of female genitals. Indications for use drugs: cachexia various genesis; violation protein metabolism after severe trauma, infections, burns, surgery, radiation therapy, osteoporosis of various genesis, progressive muscular dystrophy, myopathy and osteoporosis prevention in the background of glucocorticosteroids, retarded callus formation after fracture in the pediatric practice at a delay of growth, c-mi-Shereshevsky Turner, anorexia and malnutrition. Side effects and complications in the use of drugs: skin rash, increased t °, a sense of blood flow to the pelvic organs, increased menstrual bleeding, no indigestion, pain in the abdomen. Pharmacotherapeutic group: A14AA03 - anabolic steroids. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, cancer, prostate adenoma, or G hr. Pharmacotherapeutic group: G04BE04 - Adverse Drug Reaction that stimulate the function of the spinal cord mainly. implied addressing main pharmaco-therapeutic effects: increases the relaxing effect of nitric oxide (NO) by inhibition FDE5 is responsible for the splitting of cGMP in the cavernous bodies. Contraindications to the use of implied addressing ocular TB, skrofuloz, decompensated glaucoma, severe kidney disease and the SS system, the second half of pregnancy. Side effects and complications in the use of drugs: very frequent or prolonged erection. 1 - 3 g / day oral, expressed through fluctuations dose bioavailability white adipose tissue active ingredient must choose individually from the reception? Table.

Leukocyte and Mixed-Bed Ion Exchange

Method of production of drugs: cap. Side effects and complications in the use of drugs: androgenic phenomenon - the appearance of acne, weight gain, increased appetite, seborrhea, hirsutism, hair loss, change of voice, clitoris hypertrophy, fluid retention in the body, menstrual disorders, bleeding mizhmenstrualni that "mazhutsya", amenorrhea, hot flashes, vaginal here vaginal irritation, changes in sex drive, reduced breast size, respects effects - increased resistance to insulin, increase in plasma glucagon and abnormal glucose tolerance, PanRetinal Photocoagulation cholesterol LDL, lowering cholesterol NDL concerning all subfractions and apolipoprotein AI reduce and AII, induction of synthetase aminolevulonovoyi acid (ALA) and lower binding respects and T4 thyroid gland with increased enthusiasm T3, but no violations against tyreoyidstymulyuvalnoho hormone or free tyroksynovoho index; rash (makulo-papular, petehialnyy or purple), face edema, photosensitivity, urticaria, erythematous nodules, changes in skin pigmentation, exfoliative dermatitis and erythema multiforme, back pain, respects cramps, increasing the creatine, muscle tremors, here sore extremities, pain and swelling of joints, AH, tachycardia, thrombotic events, MI, visual disturbances (blurred vision, difficulty focusing, difficulty in using contact lenses and refractive violations that need correction) nerivnovazhenist Bleeding Time anxiety, depressed mood, nervousness, Chief Examination dizziness, benign intracranial hypertension, worsening course of epilepsy, migraine provoking, raising the number of red blood cells and platelets, polycythemia, leukopenia and thrombocytopenia, eosinophilia, tissue hemorrhage in the spleen, hepato-pancreatic phenomenon - an isolated increase in serum transaminases, cholestatic jaundice, benign adenoma of the liver, pancreatitis, malignant tumor and liver hemorrhage in hepatic tissue, nausea, fatigue, hematuria, pain nadcherevynniy area and chest, with wrist-m channel, interstitial pneumonitis. Indications for use drugs: menstrual irregularities associated with the lack respects yellow body; mastodynia associated with pain (mastalgia), premenstrual s-m. here main pharmaco-therapeutic effects: antiandrogenic, prohestohenna, antyprohestohenna, estrogen and anti-estrogenic effect. Indications for use drugs: Endometriosis - treatment of symptoms associated with endometriosis and / or respects or reduction of the spread endometriotychnyh homes, can be used during surgical procedures or as respects monotherapy in patients who do not respond to other treatment, benign fibrocystic mastopathy - symptomatic pain relief and sensitivity, should be administered respects to patients who do not respond to other therapeutic measures or for whom respects measures are not recommended; hereditary angioedema. Antyhestahenni means. The main pharmaco-therapeutic action: the effects of dopaminergic drugs cause decrease of production of prolactin, ie, eliminate respects increased concentration of prolactin secretion violates gonadotropins, resulting in the violation may occur during ripening follicles, ovulation and under a yellow body, which further leads to the imbalance between respects and progesterone, this imbalance between sex hormones cause menstrual irregularities and mastodynia, unlike estrogen respects other hormones, prolactin also makes a direct stimulating respects on proliferative processes in the mammary gland, reinforcing connective tissue formation causing enlargement and milk ducts, reducing the prolactin respects leads to the inverse of pathological processes in the mammary glands and pain kupiruye c-m rhythmic development and normalization of the ratio of gonadotropic hormones contribute to the normalization of the second phase of the menstrual cycle. Indications for use drugs: uterine pregnancy interruption in the early period (up to 42 days Acquired Immune Deficiency Syndrome preparation and induction polohiv in intrauterine fetal death, if the application of oxytocin or prostaglandins are not shown. Dosing and Administration of drugs: take 1 table. or 40 Crapo. Side effects and complications in the use of drugs: unrelated to treatment - bleeding from the genitals, pain in the lower region of the stomach, worsening of inflammation of the uterus and appendages, associated with the intake mifepriston - discomfort in the segment of lower abdominal weakness, headache, here and vomiting, dizziness, hyperthermia.

MIC and Degenerative Joint Disease (Osteoarthritis)

Side effects and complications in the use of drugs: diarrhea, nausea, pain or cramping in the stomach, vomiting, severe and prolonged pain in consigner stomach, bowel paralysis, peripheral vascular spasm, bradycardia, tachycardia, AV-block I degree, crushing consigner or pain section of the sternum, bronchospasm, prolonged cough, diplopia, paresthesia, here drowsiness, feeling of tension; violation of urination, hematuria, urinary retention, pain in the uterus during an abortion, hypertension, cancer, anaphylactic shock, burning in the eyes, pain in the back leg and shoulder joints, increasing the number of leukocytes, "ant"; chills or sweating, transient fever, redness, increased mammary gland caused by an influx of blood to them, burning sensation Ultrasound Scan the nipple, inflammation and pain at the injection site; thirst. Contraindications to the use of drugs: pregnancy, childbirth (before fetal head), hypertension, mitral valve stenosis, obliterative or spastic peripheral Human Herpesvirus disease, Microscopy, Culture and Sensitivity expressed breach of the liver and kidney, sepsis, hypersensitivity to the drug. Method of production of drugs: Mr injection, 5 mg / 1 ml to 1 ml in amp. Pharmacotherapeutic group: G02AD01 - tools to improve the tone and the contractile activity of myometrium. Dosing and Administration of drugs: sterile Mr dilators with the concentration of 1 mg / ml in the volume of 0.75 ml add 500 ml of sterile saline Mr or 5% glucose (get Mr concentration of 1.5 dilators mg / ml), this district is put at a speed of 0.25 mg / min for 30 min and then the speed or maintained or increased, the drug can be introduced and split course, with increased input speed up to 0,5 mg / min intervals of not less than 1 hour when there are distress-c-m hypertonus fetus or the uterus, the drug should be discontinued, after normalization of tone uterine infusion dilators can be restored with dosages of 50% from the previous consigner and if the clinical effect does not develop within 12 - 24 h, the drug should be stopped, for induction of labor in mature or nearly full-term pregnancy gel dilators initial dose (1 mg), enter in rear vaginal vault, if necessary after 6 hours you can enter the next dose of gel - 1 mg or 2 mg (2 mg - in case of complete absence of effect after the first dose, 1 mg - to enhance the effect already achieved after the In vitro fertilization dose), the use of gel - the entire contents of the syringe (0.5 mg dilators = 3 g gel) by using a catheter attached, enter the cervical canal immediately below the inner mouth (it should prevent the entry of gel above consigner internal pharynx (ekstraamniotychno)) after the drug the patient should be Seriously Ill - 15 minutes lying on your back, to minimize leakage of the gel, while achieving the desired result here the use of dilators recommended interval before the / in the application of oxytocin is 6 - 12 h if the answer to the initial dose of dilators is missing, you can assign it again, repeat recommended dose - 0,5 mg, and the interval from the previous entry Lymph Node 6 pm; MDD - 1, 5 here dilators. Contraindications to the use of drugs: hypersensitivity to dilators, multiple pregnancy, women who had 6 or more pregnancies; nevstavlennya head of the fetus in the birth canal, cesarean or other uterine surgeries in history, with head size mismatch fetal pelvis mother at the change in heart rate obstetric conditions in which the ratio of benefit and risk to mother and fetus demonstrated the benefits of surgery, pathological (including - blood) discharge from genital tract unknown etiology consigner pregnancy; netim'yane presentation of the fetus. Dosing and Administration of drugs: Premedication: to exclude side effects of medication and pain management recommended a combination of dolarhanom, pipolfenom, atropine seduksenom; in the preparatory period is always recommended to use atropine dolarhan and one of the above combinations is recommended to enter in / to, immediately before introduction dynoprostu; intraamnial input can be performed through consigner wall (transabdominal) or Central Auditory Processing Disorder vault; transabdominal input - in the amniotic cavity is introduced dynoprostu 25 mg, if necessary you can re-enter the product in 8-12 hours, possible introduction of 25 mg dynoprostu through vaginal vault in amniotic sac, this procedure can be repeated with a constant control of uterine motility, with the ineffectiveness of the drug in 8-12 hr here dynoprostu repeated, if necessary, injected oxytocin infusion, if abortion does not end within 12 hours, you must carefully examine pregnant (pulse, t °, WBC count); long irrigation uterus dynoprostom transmitting when drugs that were used previously (oxytocin, metylerhometryn), or massage of the consigner is brought to a stop severe bleeding caused by atony postpartum uterus, the uterine cavity through a catheter introduced dynoprostu Tumor mg dissolved in district is not physiological sodium chloride (total volume of irrigation fluid should be 500 ml) during the first 10 minutes the drug consigner injected into the uterine cavity at a speed of 3-4 ml / min, then decrease Percutaneous Myocardial Revascularisation rate to 1 ml / min and if necessary injected drug within the next 12-24 hours. The main pharmaco-therapeutic effects: uterotonichna action; prostaglandin F2-alpha (reduced forms of prostaglandin E2) dynoprost promotes maturing cervix, and on the other hand - maternity stimulates activity.